“Prescription of Glucagon-Like Peptide 1 (GLP-1) in the Treatment of Patients With Type 2 Diabetes and Obesity: A Literature Review”. 2022. Revista Eletrônica Acervo Médico 11 (June): e10289. https://doi.org/10.25248/reamed.e10289.2022.